GRPR and neoplasm: The better tumor uptake of [177Lu]Lu-LW01110 and [177Lu]Lu-LW01142 compared with the GRPR antagonist [177Lu]Lu-TacsBOMB5 also contributed to their better tumor/blood and tumor/muscles uptake ratios.